- Home
- IH vs ENTA Comparison
IH vs ENTA Comparison
Compare IH & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IH
- ENTA
- Stock Information
- Founded
- IH 1996
- ENTA 1995
- Country
- IH China
- ENTA United States
- Employees
- IH N/A
- ENTA N/A
- Industry
- IH Other Consumer Services
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- IH Real Estate
- ENTA Health Care
- Exchange
- IH Nasdaq
- ENTA Nasdaq
- Market Cap
- IH 146.3M
- ENTA 164.6M
- IPO Year
- IH 2020
- ENTA 2013
- Fundamental
- Price
- IH $3.07
- ENTA $7.54
- Analyst Decision
- IH
- ENTA Strong Buy
- Analyst Count
- IH 0
- ENTA 5
- Target Price
- IH N/A
- ENTA $20.20
- AVG Volume (30 Days)
- IH 18.1K
- ENTA 168.0K
- Earning Date
- IH 09-22-2025
- ENTA 08-11-2025
- Dividend Yield
- IH 2.85%
- ENTA N/A
- EPS Growth
- IH N/A
- ENTA N/A
- EPS
- IH 0.26
- ENTA N/A
- Revenue
- IH $123,701,096.00
- ENTA $64,806,000.00
- Revenue This Year
- IH $39.02
- ENTA N/A
- Revenue Next Year
- IH N/A
- ENTA $1.65
- P/E Ratio
- IH $11.26
- ENTA N/A
- Revenue Growth
- IH N/A
- ENTA N/A
- 52 Week Low
- IH $1.47
- ENTA $4.09
- 52 Week High
- IH $3.60
- ENTA $13.37
- Technical
- Relative Strength Index (RSI)
- IH 60.00
- ENTA 40.89
- Support Level
- IH $2.80
- ENTA $7.28
- Resistance Level
- IH $3.16
- ENTA $8.86
- Average True Range (ATR)
- IH 0.16
- ENTA 0.53
- MACD
- IH 0.03
- ENTA -0.20
- Stochastic Oscillator
- IH 85.40
- ENTA 13.76
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.